{"date":"2026-09-30","count":36,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4120-2026-09-30-2053-1avqz6f","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-09-30","time":"20:53:47","subject":"本公司董事會決議處分康霈生技股份有限公司普通股","clause":"第20款","fact_date":"2027-09-30","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-09-30 20:53，「本公司董事會決議處分康霈生技股份有限公司普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-09-30-2053-t39aam","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-09-30","time":"20:53:37","subject":"本公司處分康霈生技股份有限公司普通股","clause":"第20款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-09-30 20:53，「本公司處分康霈生技股份有限公司普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-09-30-1939-1ppdxag","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"19:39:30","subject":"公告本公司董事逝世","clause":"第6款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-09-30 19:39，「公告本公司董事逝世」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-09-30-1938-p67uuk","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-09-30","time":"19:38:19","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-09-30 19:38，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-09-30-1919-vcc5vi","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"19:19:21","subject":"公告本公司總經理逝世","clause":"第6款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-09-30 19:19，「公告本公司總經理逝世」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-09-30-1911-njoewi","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"19:11:29","subject":"本公司開發中新藥ELIXCYTE-CKD向台灣衛生福利部食品藥物管理署(TFDA)提出治療慢性腎臟病第II/III期臨床試驗審查(IND)","clause":"第10款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-09-30 19:11，「本公司開發中新藥ELIXCYTE-CKD向台灣衛生福利部食品藥物管理署(TFDA)提出治療慢性腎臟病第II/III期臨床」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-09-30-1908-rcgt4n","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"19:08:19","subject":"公告本公司115年8月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-09-30 19:08，「公告本公司115年8月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6797-2026-09-30-1900-1496nuq","company_id":"6797","company":"圓點奈米","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"19:00:22","subject":"公告本公司發言人逝世","clause":"第11款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：圓點奈米（6797），2026-09-30 19:00，「公告本公司發言人逝世」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-09-30-1852-fhbdz2","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"18:52:57","subject":"代重要子公司StemCyte, Inc. (美國永生公司)公告向臺灣衛生福利部食品藥物管理署申請臍帶血細胞製劑REGENECYTE再生醫療製劑查驗登記(NDA)","clause":"第10款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-09-30 18:52，「代重要子公司StemCyte, Inc. (美國永生公司)公告向臺灣衛生福利部食品藥物管理署申請臍帶血細胞製劑REGEN」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-09-30-1826-hanwlm","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"18:26:03","subject":"本公司口服胜月太藥品(ANY004)澳洲一期臨床試驗取得正向人體數據","clause":"第8款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-09-30 18:26，「本公司口服胜月太藥品(ANY004)澳洲一期臨床試驗取得正向人體數據」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-09-30-1758-qmd25j","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"17:58:11","subject":"公告本公司取得簽證會計師內部控制專案審查報告","clause":"第25款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-09-30 17:58，「公告本公司取得簽證會計師內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-09-30-1754-1vdwe7l","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"17:54:43","subject":"公告董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第9款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-09-30 17:54，「公告董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-09-30-1718-qp2ad","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"17:18:53","subject":"本公司董事會授權董事長訂定現金股利除息基準日及發放日等相關事宜","clause":"第14款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-09-30 17:18，「本公司董事會授權董事長訂定現金股利除息基準日及發放日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-09-30-1718-1csx57f","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"17:18:16","subject":"公告本公司調整現金股利總額","clause":"第14款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-09-30 17:18，「公告本公司調整現金股利總額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-09-30-1713-1k5ezp2","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"17:13:06","subject":"公告本公司接獲主管機關核准展延115年第2季財務報告之重行公告申報期限。","clause":"第24款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-09-30 17:13，「公告本公司接獲主管機關核准展延115年第2季財務報告之重行公告申報期限。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-09-30-1700-85ni8k","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"17:00:58","subject":"公告本公司董事會決議設立竹北分公司並委任分公司經理人","clause":"第44款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-09-30 17:00，「公告本公司董事會決議設立竹北分公司並委任分公司經理人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-09-30-1700-1w8vb1u","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"17:00:32","subject":"公告本公司財務長、財務主管、會計主管異動暨由職務代理人暫代職務","clause":"第11款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-09-30 17:00，「公告本公司財務長、財務主管、會計主管異動暨由職務代理人暫代職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-09-30-1659-1jhewlf","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"16:59:48","subject":"公告本公司公司治理主管異動","clause":"第11款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-09-30 16:59，「公告本公司公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-09-30-1658-ctjdv","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"16:58:53","subject":"公告本公司設置資安長","clause":"第11款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-09-30 16:58，「公告本公司設置資安長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-09-30-1658-kxgk3x","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"16:58:28","subject":"公告本公司發言人及代理發言人異動","clause":"第11款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-09-30 16:58，「公告本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-09-30-1657-1qdviyv","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-09-30","time":"16:57:05","subject":"代重要子公司豐華生物科技(股)公司公告向關係人取得使用權資產(調整租賃面積及增加管理費)","clause":"第20款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-09-30 16:57，「代重要子公司豐華生物科技(股)公司公告向關係人取得使用權資產(調整租賃面積及增加管理費)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-09-30-1643-1h37mho","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"16:43:32","subject":"代子公司康誠生技股份有限公司公告向關係人處分不動產使用權資產(提前終止租約)","clause":"第17款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-09-30 16:43，「代子公司康誠生技股份有限公司公告向關係人處分不動產使用權資產(提前終止租約)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-09-30-1643-13iz97c","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"16:43:10","subject":"代重要子公司康儀科技股份有限公司公告向關係人處分不動產使用權資產(提前終止租約)","clause":"第17款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-09-30 16:43，「代重要子公司康儀科技股份有限公司公告向關係人處分不動產使用權資產(提前終止租約)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-09-30-1629-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"16:29:55","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-09-30 16:29，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-09-30-1559-1y8efhg","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-09-30","time":"15:59:49","subject":"代子公司康君諮詢管理(上海)公告累計取得理財產品達公告標準","clause":"第20款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-09-30 15:59，「代子公司康君諮詢管理(上海)公告累計取得理財產品達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-09-30-1549-npqnia","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"15:49:31","subject":"(更正文字)公告本公司董事會決議通過私募普通股補辦公開發行及申請登錄興櫃","clause":"第44款","fact_date":"2026-09-09","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-09-30 15:49，「(更正文字)公告本公司董事會決議通過私募普通股補辦公開發行及申請登錄興櫃」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-09-30-1546-dforwu","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"15:46:11","subject":"公告本公司115年現金增資訂定認股基準日相關事宜","clause":"第9款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-09-30 15:46，「公告本公司115年現金增資訂定認股基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-09-30-1542-tn9yof","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"15:42:24","subject":"公告本公司董事會決議私募方式辦理國內無擔保普通公司債","clause":"第11款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-09-30 15:42，「公告本公司董事會決議私募方式辦理國內無擔保普通公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-09-30-1536-1pegjge","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"15:36:53","subject":"代重要子公司Tanvex BioPharma USA, Inc.及台灣泰福生技股份有限公司公告人事異動","clause":"第8款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-09-30 15:36，「代重要子公司Tanvex BioPharma USA, Inc.及台灣泰福生技股份有限公司公告人事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-09-30-1536-1nxb0oo","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"15:36:51","subject":"因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第51款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-09-30 15:36，「因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-09-30-1535-1q6wz7h","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"15:35:51","subject":"公告本公司人事異動","clause":"第8款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-09-30 15:35，「公告本公司人事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-09-30-1508-uzxms1","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"15:08:08","subject":"代重要子公司新高製藥(股)有限公司公告法人董事代表人辭任。","clause":"第6款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-09-30 15:08，「代重要子公司新高製藥(股)有限公司公告法人董事代表人辭任。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-09-30-1506-sdqnnp","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"15:06:29","subject":"公告本公司重要營運主管辭職。","clause":"第8款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-09-30 15:06，「公告本公司重要營運主管辭職。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-09-30-1505-8whx8j","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"15:05:52","subject":"公告本公司法人董事代表人辭任。","clause":"第6款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-09-30 15:05，「公告本公司法人董事代表人辭任。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-09-30-1447-eiyy7b","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-09-30","time":"14:47:19","subject":"代重要子公司保盛藥業股份有限公司公告處分Megestrol Acetate Oral Suspension藥證及相關權利案","clause":"第20款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-09-30 14:47，「代重要子公司保盛藥業股份有限公司公告處分Megestrol Acetate Oral Suspension藥證及相關權利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-09-30-1316-er5zy1","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-09-30","time":"13:16:10","subject":"本公司與順天堂藥廠股份有限公司簽訂「中草藥健康種苗代培暨技術合作契約書」","clause":"第8款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-09-30 13:16，「本公司與順天堂藥廠股份有限公司簽訂「中草藥健康種苗代培暨技術合作契約書」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}